POET's November 16 report tests a $0.7 million quarter against its Malaysia 800G promise
The company told investors on October 16 that the quarter it promised high-volume 800G output in Malaysia reports in 27 days. A projection of $138.4 million in 2027 revenue is circulating against a September quarter the market expects at roughly $0.7 million.
Vincent Jiang · 3 min read
POET Technologies−0.91% — POET Technologies, down 0.91 percent today has put a date on its own exam. On October 16, the Toronto photonics designer said it will report third-quarter results on November 16, before the open, and will begin regular quarterly earnings calls with the full-year print expected March 1, 2027.12 That quarter just closing is the one the company said would carry its Malaysia line into high-volume 800G engine production, on a year guided to more than 30,000 optical engines shipped.3 Twenty-seven days from today, on November 16, investors learn whether it held.
A rebuilt company hangs on one customer
The stakes are set. On May 14, POET signed a supply agreement with Lumilens carrying an initial $50 million order, built to pass $500 million over five years if qualification succeeds; engineering samples are due late this year and volume production in 2027. A warrant for 22.9 million shares at $8.25 vests only as Lumilens payments land.4 It is the sole anchor customer after Marvell−1.94% — Marvell, down 1.94 percent today, following a CFO video interview on April 21, canceled every POET purchase order on April 23 over what it called unauthorized disclosure, and the stock fell 47.3% in a day.4
The circulating projection sits far above the ledger
The circulating projection has 2027 revenue at 30 times 2026's expected $4.67 million: $138.4 million, with a price target of about $15 a share, while management's own 2028 goal is $300 million.356 Against that, the market expects the September quarter at roughly $0.7 million of revenue, up from $0.5 million, and lifetime revenue since 2020 is only $2.3 million.57 Second-quarter revenue was $569,925, the sixth straight sequential rise, against a $12.2 million quarterly operating cash outflow and negative gross profit.46 Short interest stood at 22.8 million shares at the September 15 settlement, and the stock closed October 15 at $5.43, a market cap of $939.7 million, down from $7.79 on October 9, with a securities suit over the April disclosure still pending.34
The cash burn deepened even as revenue rose: a record $12.3 million outflow in the June quarter
Data
| Operating cash flow | |
|---|---|
| Q3 '24 | -$5,500,000M |
| Q4 '24 | -$8,690,000M |
| Q1 '25 | -$8,980,000M |
| Q2 '25 | -$7,740,000M |
| Q3 '25 | -$2,770,000M |
| Q4 '25 | -$11,600,000M |
| Q1 '26 | -$8,810,000M |
| Q2 '26 | -$12,270,000M |
Six straight quarters of revenue growth, to $570,000 in the June quarter
Data
| Value | |
|---|---|
| Q4 '24 | 30 |
| Q1 '25 | 170 |
| Q2 '25 | 270 |
| Q3 '25 | 300 |
| Q4 '25 | 340 |
| Q1 '26 | 500 |
| Q2 '26 | 570 |
What November 16 settles
The bear argument needs no embellishment: $830 million of equity issued this year, a promise-driven valuation against a $0.7 million quarter.4 The bull case is timing. Lumentum's−2.48% — Lumentum, down 2.48 percent today chief executive said his optical parts are "completely sold out" through early 2029, demand exceeds supply by about an order of magnitude, and POET holds $796.3 million in cash.45 A sold-out market forgives a slow quarter less than a shipped one. Watch November 16 for three lines: revenue against the $0.7 million consensus, confirmation that high-volume 800G output started in Malaysia in the third quarter, and any second customer. A miss does not kill the Lumilens deal; a silent quarter with no new name makes the warrant's $8.25 strike, standing $2.82 above the October 15 close, look further out of reach than it did when it was signed.34
Deepdive
AI-generated from this story and its cited sources. Not investment advice.



